Indie developer Explosive Squat Games has released a surprise upgraded remaster for the original Intravenous, their brutal tactical shooter from a few years ago.
While the second Intravenous was released last year to much fanfare and brought with it new gameplay mechanics and polish, the original game might have felt a bit rough for fans wanting the first part of the series.
To remedy this, Explosive Squat released a surprise upgraded remaster for the original game, what they’re lovingly dubbing “Intravenous 1 2.0”, bringing the feel of the original game but adapting its levels with improvements from the sequel.
The new Intravenous remaster is now available as paid downloadable content for the second game (so you need to own Intravenous 2), and is currently 10% off its $9.99 price tag.
Here’s a rundown on the new remaster, plus a trailer:
Experience the game where it all began the way the developer intended the game to be.
Various new features present in Intravenous 2 were meant to be included in the first game, but were ultimately cut due to time & budget constraints.
This campaign port is as much a port as it is “Intravenous 1 2.0” – keeping the feel of the original, while adapting the game levels to the new gameplay mechanics of the sequel, and bringing a level of polish to the overall package to make it a much better experience all around.
Key features:
- Updated game levels. The campaign looks & plays better with improved layouts, new routes to allow for more gameplay variety, and are adapted to the game design of Intravenous 2.
- Updated soundtrack. VIP (variation in production) tracks for all levels, including new tracks for levels that didn’t have their own, by the extremely talented Xtrullor.
- Refined narrative. Dialogues and cutscenes received changes to keep narrative quality consistent, while preserving the atmosphere of the first game.
- Bells & whistles. Experience all the improvements done to the sequel in this campaign remaster. Want an even bigger juxtaposition? Try playing the original after this.